Exelixis Inc - Company Profile
Powered by 
All the data and insights you need on Exelixis Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Exelixis Inc Strategy Report
- Understand Exelixis Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on Exelixis Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Exelixis Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Stelios Papadopoulos, Ph.D.
Chairman Executive BoardDr. Stelios Papadopoulos has been the Chairman of the company since 1998. Prior to this, he served as the Vice Chairman of Cowen & Co LLC since 2006. Dr. Papadopoulos also served as an Investment Banker at PaineWebber, Incorporated; Chairman of PaineWebber Development Corp. Previously, he served as the Vice President in the Equity Research Department of Drexel Burnham Lambert in 1987.
Michael M. Morrissey, Ph.D.
Director; President; Chief Executive Officer Executive BoardDr. Michael M. Morrissey has been the President, the Chief Executive Officer and a Director of the company since 2010. Prior to this, he served as President of Research and Development from 2007 to 2010 of the company. Dr. Morrissey also served as the Executive Vice President, Discovery in 2006; Senior Vice President, Discovery from 2003 to 2005 and Vice President of Discovery Research from 2000 to 2002. He served at Berlex Biosciences as Vice President of Discovery Research, Senior Scientist and Project Team Leader in Medicinal Chemistry at CIBA-Geigy Corporation from 1986 to 1991.
Christopher J. Senner
Chief Financial Officer; Executive Vice President Senior ManagementMr. Christopher J. Senner has been the Executive Vice President and Chief Financial Officer of the company since 2015. Prior to this, he served as Vice President, Corporate Finance at Gilead Sciences in 2010. Mr. Senner also served as the Vice President, Finance and Chief Financial Officer for Wyeth Pharmaceutical's U.S. Region from 2007 to 2009.
Amy Peterson, M.D
Chief Medical Officer; Executive Vice President - Product Development and Medical Affairs Senior ManagementDr. Amy Peterson has been the Executive Vice President, Product Development & Medical Affairs, and Chief Medical Officer of the company since August 2023. Previously, she served as the President and Chief Operating Officer at CytomX. Prior to that, Dr. Peterson served as the Executive Vice President and Chief Development Officer at CytomX.
Dana T. Aftab, Ph.D.
Chief Scientific Officer; Executive Vice President - Discovery and Translational Research Senior ManagementMr. Dana T. Aftab has been the Chief Scientific Officer and Executive Vice President at Discovery and Translational Research of the company since 2022. Prior to this, he served as the Senior Vice President of Translational Research from 2009 to 2016. Most recently, Dr. Aftab served as the company’s Executive Vice President of Business Operations. He also served as senior scientist at several biotech start-ups.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer